Registered entities
Innovation
7 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 2,239 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 3 |
Social engagement
Social engagement: 26.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
26 investors on record; lead investors include Novo Holdings, Samsara BioCapital, CAM Capital, Quan Capital; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 38% |
| Private equity | 3 | 12% |
| Angel & family office | 1 | 4% |
| Other / undisclosed | 12 | 46% |
Hiring activity
Hires periodically
13 roles tracked across 3 of the last 12 months
2 Feb 2026 · Regional Director, Medical Science Liaisons (West) · Phoenix
12 Jan 2026 · Senior Director, Statistical Programming · Redwood City
22 Nov 2025 · Senior Cell Therapy Account Manager (Seattle) · Denton
22 Nov 2025 · Senior Cell Therapy Account Manager (Indianapolis-Michigan) · Murrieta
21 Nov 2025 · Senior Cell Therapy Account Manager (Raleigh) · Raleigh
Based on job postings tracked across public sources.